Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 4
2015 3
2017 3
2018 2
2019 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer.
López-Menéndez C, Vázquez-Naharro A, Santos V, Dubus P, Santamaría PG, Martínez-Ramírez Á, Portillo F, Moreno-Bueno G, Faraldo MM, Cano A. López-Menéndez C, et al. Cancer Res. 2021 Sep 1;81(17):4529-4544. doi: 10.1158/0008-5472.CAN-20-2685. Epub 2021 Jun 18. Cancer Res. 2021. PMID: 34145034 Free PMC article.
Loxl2 is dispensable for dermal development, homeostasis and tumour stroma formation.
Kober KI, Cano A, Géraud C, Sipilä K, Mobasseri SA, Philippeos C, Pisco AO, Stannard A, Martin A, Salvador F, Santos V, Boutros M, Rognoni E, Watt FM. Kober KI, et al. PLoS One. 2018 Jun 28;13(6):e0199679. doi: 10.1371/journal.pone.0199679. eCollection 2018. PLoS One. 2018. PMID: 29953488 Free PMC article.
Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.
Salvador F, Martin A, López-Menéndez C, Moreno-Bueno G, Santos V, Vázquez-Naharro A, Santamaria PG, Morales S, Dubus PR, Muinelo-Romay L, López-López R, Tung JC, Weaver VM, Portillo F, Cano A. Salvador F, et al. Cancer Res. 2017 Nov 1;77(21):5846-5859. doi: 10.1158/0008-5472.CAN-16-3152. Epub 2017 Jul 18. Cancer Res. 2017. PMID: 28720577 Free PMC article.
12 results